Chiara Santagata

Chiara Santagata


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
AVAnnamaria Venanzi
Annamaria Venanzi
PFPaola Di Filippo
Paola Di Filippo
CSChiara Santagata
Chiara Santagata
SPSabrina Di Pillo
Sabrina Di Pillo
Francesco ChiarelliFrancesco Chiarelli
Francesco Chiarelli
Marina AttanasiMarina Attanasi
Marina Attanasi
High-flow nasal cannula (HFNC) therapy is a non-invasive ventilatory support that has gained interest over the last ten years as a valid alternative to nasal continuous positive airway pressure (nCPAP) in children with respiratory failure. Its safety, availability, tolerability, and easy management have resulted its increasing usage, even outside intensive care units. Despite its wide use in daily clinical practice, there is still a lack of guidelines to standardize the use of HFNC. The aim of this review is to summarize current knowledge about the mechanisms of action, safety, clinical effects, and tolerance of HFNC in children, and to propose a clinical practices algorithm for children with respiratory failure.